Abstract:Cancer is one of the most dangerous threats to human health. One of the issues is drug resistance action, which leads to side effects after drug treatment. Numerous therapies have endeavored to relieve the drug resistance action. Recently, anticancer peptides could be a novel and promising anticancer candidate, which can inhibit tumor cell proliferation, migration, and suppress the formation of tumor blood vessels, with fewer side effects. However, it is costly, laborious and time consuming to identify anticancer peptides by biological experiments with a high throughput. Therefore, accurately identifying anti-cancer peptides becomes a key and indispensable step for anticancer peptides therapy. Although some existing computer methods have been developed to predict anticancer peptides, the accuracy still needs to be improved. Thus, in this study, we propose a deep learning-based model, called ACPNet, to distinguish anticancer peptides from non-anticancer peptides (non-ACPs). ACPNet employs three different types of peptide sequence information, peptide physicochemical properties and auto-encoding features linking the training process. ACPNet is a hybrid deep learning network, which fuses fully connected networks and recurrent neural networks. The comparison with other existing methods on ACPs82 datasets shows that ACPNet not only achieves the improvement of 1.2% Accuracy, 2.0% F1-score, and 7.2% Recall, but also gets balanced performance on the Matthews correlation coefficient. Meanwhile, ACPNet is verified on an independent dataset, with 20 proven anticancer peptides, and only one anticancer peptide is predicted as non-ACPs. The comparison and independent validation experiment indicate that ACPNet can accurately distinguish anticancer peptides from non-ACPs.

ACP-GCN: The Identification of Anticancer Peptides Based on Graph Convolution Networks

GCNCPR-ACPs: a Novel Graph Convolution Network Method for ACPs Prediction.

ACPNet: A Deep Learning Network to Identify Anticancer Peptides by Hybrid Sequence Information

DeepACP: A Novel Computational Approach for Accurate Identification of Anticancer Peptides by Deep Learning Algorithm

CACPP: A Contrastive Learning-Based Siamese Network to Identify Anticancer Peptides Based on Sequence Only.

ACP-DL: A Deep Learning Long Short-Term Memory Model to Predict Anticancer Peptides Using High-Efficiency Feature Representation

Peptide-Based Drug Predictions for Cancer Therapy Using Deep Learning

Inacp: an Integrated Approach to the Prediction of Anticancer Peptides.

Prediction of anticancer peptides based on an ensemble model of deep learning and machine learning using ordinal positional encoding

Anti-cancer Peptide Recognition Based on Grouped Sequence and Spatial Dimension Integrated Networks

ACPScanner: Prediction of Anticancer Peptides by Integrated Machine Learning Methodologies

EnACP: an Ensemble Learning Model for Identification of Anticancer Peptides

ACP-ML: A sequence-based method for anticancer peptide prediction

ME-ACP: Multi-view Neural Networks with Ensemble Model for Identification of Anticancer Peptides

Effective identification and differential analysis of anticancer peptides

ACP-check: An anticancer peptide prediction model based on bidirectional long short-term memory and multi-features fusion strategy

DRACP: a Novel Method for Identification of Anticancer Peptides.

ACP-ESM2: The Prediction of Anticancer Peptides Based on Pre-trained Classifier

iACP-DFSRA: Identification of Anticancer Peptides Based on a Dual-channel Fusion Strategy of ResCNN and Attention

AMA-GCN: Adaptive Multi-layer Aggregation Graph Convolutional Network for Disease Prediction

Anticancer Peptide Prediction <i>via</i> Multi-Kernel CNN and Attention Model